At the pilot sites, PV/LPVs in breast cancer genes were most commonly identified in ATM, BRCA2, and BRCA1, whereas at the non-pilot sites, they were most commonly identified in BRCA2, BRCA1, and PALB2. This evidence concerns the gene ATM and breast carcinoma.